Inventiva discontinues lanifibranor for systemic sclerosis

Inventiva S.A. (Euronext:IVA) discontinued development of lanifibranor (IVA337) to treat diffuse cutaneous systemic sclerosis after the

Read the full 160 word article

User Sign In